Erin Colgan
Treasurer bei Massachusetts Biotechnology Education Foundation
Vermögen: 67 462 $ am 30.04.2024
Aktive Positionen von Erin Colgan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Massachusetts Biotechnology Education Foundation
Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Treasurer | - | - |
Karriereverlauf von Erin Colgan
Ehemalige bekannte Positionen von Erin Colgan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENSEI BIOTHERAPEUTICS, INC. | Verwaltungsdirektor | 01.07.2020 | 01.12.2021 |
Finanzdirektor/CFO | 01.01.2022 | 10.04.2024 | |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.08.2019 | 01.06.2020 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.08.2010 | 01.08.2019 |
Ausbildung von Erin Colgan
University of Massachusetts | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 2 |
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Massachusetts Biotechnology Education Foundation
Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Commercial Services |
- Börse
- Insiders
- Erin Colgan
- Erfahrung